ALDOMET Side Effects

6987605-9 | Platelet Count Decreased, Pyrexia
on Sep 01, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, pyrexia. Aldomet dosage: 750 Mg, Oral.

6917462-8 | Caesarean Section, Hepatic Function Abnormal
Patient was taking Aldomet (View Usage). Patient had the following side effects: caesarean section, hepatic function abnormal on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 38 years of age, was diagnosed with hypertensive nephropathy and. Aldomet dosage: 500 Mg (250 Mg, 2 In 1 D), 500 Mg (250 Mg, 2 In 1 D), Oral. During the same period patient was treated with FESIN 9SACCHARATED IRON OXIDE) (SACCHARATED IRON OXIDE) (80 Mg, Injection) (View Fesin 9saccharated Iron Oxide) (saccharated Iron Oxide) Review and Fesin 9saccharated Iron Oxide) (saccharated Iron Oxide) Label ), MAGLAX (MAGNESIUM OXIDE) (MAGNESIUM OXIDE) (View Maglax (magnesium Oxide) (magnesium Oxide) Review and Maglax (magnesium Oxide) (magnesium Oxide) Label ), APRESOLINE (View Apresoline Review and Apresoline Label ), MAGNESOL (MAGNESIUM SLUFATE) (MAGNESIUM SULFATE) (View Magnesol (magnesium Slufate) (magnesium Sulfate) Review and Magnesol (magnesium Slufate) (magnesium Sulfate) Label ), PERIDPINE (NICARDIPINE HYDROCHLORIDE) (NICARDIPINE HYDROCHLORIDE) (View Peridpine (nicardipine Hydrochloride) (nicardipine Hydrochloride) Review and Peridpine (nicardipine Hydrochloride) (nicardipine Hydrochloride) Label ), PANSPORIN (CEFOTIAM HYDROCHLORIDE) (CEFOTIAM HYDROCHLORIDE) (View Pansporin (cefotiam Hydrochloride) (cefotiam Hydrochloride) Review and Pansporin (cefotiam Hydrochloride) (cefotiam Hydrochloride) Label ).

6917382-9 | Hepatic Function Abnormal
Adverse event was reported on Jul 22, 2010 by a Female patient taking Aldomet (View Usage) (Dosage: 750 Mg (250 Mg, 3 In 1 D), 500 Mg (250 Mg, 2 In 1 D), Oral) was diagnosed with hypertension, anaemia and. Location: JAPAN , 38 years of age, After Aldomet was administered, patient had the following side effects: hepatic function abnormal. During the same period patient was treated with FESIN (SACCHARATED IRON OXIDE) (SACCHARATED IRON OXIDE) (Injection) (View Fesin (saccharated Iron Oxide) (saccharated Iron Oxide) Review and Fesin (saccharated Iron Oxide) (saccharated Iron Oxide) Label ). Patient was hospitalized.

6894456-2 | Hepatic Function Abnormal
on Jul 15, 2010 Female patient from JAPAN , 38 years of age, was diagnosed with hypertension, anaemia and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Aldomet dosage: 750 Mg (250 Mg, 3 In 1 D) Oral; 500 Mg (250 Mg, 2 In 1 D) Oral. During the same period patient was treated with FESIN (SACCHARATED IRON OXIDE) (SACCHARATED IRON OXIDE) (Injection) (View Fesin (saccharated Iron Oxide) (saccharated Iron Oxide) Review and Fesin (saccharated Iron Oxide) (saccharated Iron Oxide) Label ). Patient was hospitalized.


6862523-5 | Back Pain, Blood Creatine Phosphokinase Increased, Pyrexia
on Jul 08, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient had the following side effects: back pain (What is back pain?), blood creatine phosphokinase increased, pyrexia. Aldomet dosage: 500 Mg (2 In 1 D) Per Oral. Patient was hospitalized.

6773650-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Caesarean Section, Hydronephrosis, Oligohydramnios, Ovarian Enlargement
Patient was taking Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, caesarean section, hydronephrosis, oligohydramnios, ovarian enlargement on May 05, 2010 from PAKISTAN Additional patient health information: Female patient , 28 years of age, was diagnosed with hypertension and. Aldomet dosage: 250 Mg/bid Per Oral. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6703922-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Jaundice, Liver Disorder
Adverse event was reported on Apr 12, 2010 by a Female patient taking Aldomet (View Usage) (Dosage: 250 Mg Per Oral; 500 Mg Per Oral) was diagnosed with hypertension and. Location: JAPAN , 39 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice (What is jaundice?), liver disorder. Patient was hospitalized.

6692383-7 | Liver Disorder
on Apr 05, 2010 Female patient from JAPAN , 40 years of age, was treated with Aldomet (View Usage). Patient had the following side effects: liver disorder. Aldomet dosage: Per Oral. Patient was hospitalized.

6656942-X | Brain Oedema, Coagulopathy, Encephalopathy, Jaundice, Multi-organ Failure, Renal Failure Acute, Respiratory Failure
on Mar 29, 2010 Female patient from UNITED STATES , 40 years of age, weighting 293.2 lb, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: brain oedema, coagulopathy, encephalopathy, jaundice (What is jaundice?), multi-organ failure, renal failure acute, respiratory failure. Aldomet dosage: Unk Unk Oral 047. Patient was hospitalized.

6651319-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Foetal Growth Retardation, Gamma-glutamyltransferase Increased
Patient was taking Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, foetal growth retardation, gamma-glutamyltransferase increased on Mar 08, 2010 from GREECE Additional patient health information: Female patient , 40 years of age, was diagnosed with hypertension and. Aldomet dosage: 250 Mg (3 In 1 D), Per Oral. During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), LEVOTHYROXINE (LEVOTHYROXINE SODIUM) (LEVOTHYROXINE SODIUM) (View Levothyroxine (levothyroxine Sodium) (levothyroxine Sodium) Review and Levothyroxine (levothyroxine Sodium) (levothyroxine Sodium) Label ), MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTETONE ACETATE) (MEDROXYPROG (View Medroxyprogesterone Acetate (medroxyprogestetone Acetate) (medroxyprog Review and Medroxyprogesterone Acetate (medroxyprogestetone Acetate) (medroxyprog Label ), PROGESTERONE (PROGESTERONE) (PROGESTERONE) (View Progesterone (progesterone) (progesterone) Review and Progesterone (progesterone) (progesterone) Label ). Patient was hospitalized.

6618813-4 | Cholelithiasis, Cytolytic Hepatitis, Hepatitis Acute, Prothrombin Level Decreased
Adverse event was reported on Feb 19, 2010 by a Female patient taking Aldomet (View Usage) (Dosage: 250 Mg (1 In 1 D), Oral) was diagnosed with hypertension and. Location: FRANCE , 31 years of age, Patient had the following side effects: cholelithiasis, cytolytic hepatitis, hepatitis acute, prothrombin level decreased. During the same period patient was treated with IRBESARTAN ((1 In 1 D)) (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6610845-5 | Coombs Test Positive
on Feb 08, 2010 Female patient from JAPAN , 33 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: coombs test positive. Aldomet dosage: 750 Mg, Oral; 1500 Mg, Oral; 2000 Mg, Oral; 1500 Mg, Oral. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

6610843-1 | Aborted Pregnancy
on Jan 19, 2010 Female patient from FRANCE , 40 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: aborted pregnancy. Aldomet dosage: 500 Mg, Oral. During the same period patient was treated with LOXEN (NICARDAPINE HYDROCHLORIDE) (NICARDIPINE HYDROCHLORIDE) ((50 Mg In The Morning) (20 Mg In The Evening), Oral) (View Loxen (nicardapine Hydrochloride) (nicardipine Hydrochloride) Review and Loxen (nicardapine Hydrochloride) (nicardipine Hydrochloride) Label ), KALEORID (POTASSIUM CHLORIDE) (POTASSIUM CHLORIDE) (3000 Mg (1000 Mg, 3 In 1 D), Oral) (View Kaleorid (potassium Chloride) (potassium Chloride) Review and Kaleorid (potassium Chloride) (potassium Chloride) Label ).

6557235-1 | Cholelithiasis, Cholestasis, Cytolytic Hepatitis, Hepatitis Acute, Prothrombin Level Decreased
Patient was taking Aldomet (View Usage). Patient had the following side effects: cholelithiasis, cholestasis, cytolytic hepatitis, hepatitis acute, prothrombin level decreased on Jan 11, 2010 from FRANCE Additional patient health information: Female patient , 31 years of age, was diagnosed with hypertension and. Aldomet dosage: 250 Mg (1 In 1 D), Oral. Patient was hospitalized.

6538550-4 | Abdominal Pain, Arthralgia, Coagulopathy, Encephalopathy, Jaundice, Nausea, Pyrexia
Adverse event was reported on Jan 13, 2010 by a Female patient taking Aldomet (View Usage) (Dosage: 250 Mg Tid Oral 047) was diagnosed with hypertension and. Location: UNITED STATES , 31 years of age, weighting 366.0 lb, After Aldomet was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, coagulopathy, encephalopathy, jaundice (What is jaundice?), nausea (What is nausea?), pyrexia. Patient was hospitalized.

6496534-9 | Cytolytic Hepatitis
on Nov 25, 2009 Female patient from FRANCE , 30 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Aldomet dosage: ** (500 Mg/day); Per Oral. Patient was hospitalized.

6454803-2 | Cardiogenic Shock, Cholecystitis, Hyponatraemia, Overdose, Suicidal Ideation
on Nov 02, 2009 Female patient from GERMANY , 37 years of age, was treated with Aldomet (View Usage). Patient had the following side effects: cardiogenic shock, cholecystitis, hyponatraemia, overdose, suicidal ideation. Aldomet dosage: 10000 Mg Per Oral. During the same period patient was treated with ZESTRIL (Per Oral) (View Zestril Review and Zestril Label ), NITRENDIPINE (NITRENDIPINE) (NITRENDIPINE) (800 Mg Per Oral) (View Nitrendipine (nitrendipine) (nitrendipine) Review and Nitrendipine (nitrendipine) (nitrendipine) Label ), MOLSIDOMINE (MOLSIDOMINE) (TABLETS) (MOLSIDOMINE) (320 Mg Per Oral) (View Molsidomine (molsidomine) (tablets) (molsidomine) Review and Molsidomine (molsidomine) (tablets) (molsidomine) Label ). Patient was hospitalized.

6354496-9 | Dyspnoea, Haemodialysis, Hepatic Failure, Renal Cyst, Renal Failure Acute, Right Ventricular Failure
Patient was taking Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: dyspnoea, haemodialysis, hepatic failure, renal cyst, renal failure acute, right ventricular failure on Aug 27, 2009 from SWEDEN Additional patient health information: Male patient , 59 years of age, was diagnosed with hypertension and. Aldomet dosage: 250 Mg Per Oral. During the same period patient was treated with ARANESP (DARBEPOETIN ALFA) (30 MICROGRAM, SOLUTION) (View Aranesp (darbepoetin Alfa) (30 Microgram, Solution) Review and Aranesp (darbepoetin Alfa) (30 Microgram, Solution) Label ), PROGRAF (TACROLIMUS) (1MILLIGRAM, CAPSULES) (View Prograf (tacrolimus) (1milligram, Capsules) Review and Prograf (tacrolimus) (1milligram, Capsules) Label ), ENALAPRIL ACTAVIS (ENALAPRIL) (20 MILLIGRAM, TABLETS) (View Enalapril Actavis (enalapril) (20 Milligram, Tablets) Review and Enalapril Actavis (enalapril) (20 Milligram, Tablets) Label ), OMEPRAZOL ABCUR (OMEPRAZOLE) (20 MILLIGRAM, TABLETS) (View Omeprazol Abcur (omeprazole) (20 Milligram, Tablets) Review and Omeprazol Abcur (omeprazole) (20 Milligram, Tablets) Label ), MOMPARA (60 MILLIGRAM, TABLETS) (View Mompara (60 Milligram, Tablets) Review and Mompara (60 Milligram, Tablets) Label ), ORALOVITE (ASCORBIC ACID, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLO (View Oralovite (ascorbic Acid, Pyridoxine Hydrochloride, Thiamine Hydrochlo Review and Oralovite (ascorbic Acid, Pyridoxine Hydrochloride, Thiamine Hydrochlo Label ), IMUREL (AZATHIOPRINE) (50 MILLIGRAM, TABLETS) (AZATHIOPRINE) (View Imurel (azathioprine) (50 Milligram, Tablets) (azathioprine) Review and Imurel (azathioprine) (50 Milligram, Tablets) (azathioprine) Label ), DUROFERON (FERROUS SULFATE) (100 MILLIGRAM, TAB) (View Duroferon (ferrous Sulfate) (100 Milligram, Tab) Review and Duroferon (ferrous Sulfate) (100 Milligram, Tab) Label ). Patient was hospitalized.

6348288-4 | Haemolytic Anaemia
Adverse event was reported on Aug 12, 2009 by a Female patient taking Aldomet (View Usage) (Dosage: Oral) was diagnosed with hypertension and. Location: SPAIN , 40 years of age, Patient experienced the following unwanted or unexpected effects: haemolytic anaemia.

6334983-X | Coombs Positive Haemolytic Anaemia
on Aug 12, 2009 Female patient from SPAIN , 40 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient had the following side effects: coombs positive haemolytic anaemia. Aldomet dosage: Oral.

6314781-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Aug 07, 2009 Female patient from JAPAN , 33 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Aldomet dosage: 1500 Mg Oral. Patient was hospitalized.

6306945-X | Liver Disorder
Patient was taking Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Jul 30, 2009 from JAPAN Additional patient health information: Female patient , 33 years of age, . Aldomet dosage: . Patient was hospitalized.

6289043-3 | Pyrexia, Rash
Adverse event was reported on Jul 07, 2009 by a Female patient taking Aldomet (View Usage) (Dosage: 250 Mg) was diagnosed with hypertension and. Location: JAPAN , 67 years of age, Patient had the following side effects: pyrexia, rash (What is rash?). During the same period patient was treated with OLMETEC (View Olmetec Review and Olmetec Label ), ALMARL (AROTINOLOL HYDROCHLORIDE) (AROTINOLOL HYDROCHLORIDE) (View Almarl (arotinolol Hydrochloride) (arotinolol Hydrochloride) Review and Almarl (arotinolol Hydrochloride) (arotinolol Hydrochloride) Label ). Patient was hospitalized.

6277639-4 | Dialysis, Feeling Abnormal, Pyrexia, Rash
on Jul 07, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: dialysis (What is dialysis?), feeling abnormal, pyrexia, rash (What is rash?). Aldomet dosage: (250 Mg), Oral. During the same period patient was treated with OLMETEC (View Olmetec Review and Olmetec Label ), ALMARL (AROTTNOLOL HYDROCHLORIDE)(AROTINOLOT, HYDROCHLORIDE) (View Almarl (arottnolol Hydrochloride)(arotinolot, Hydrochloride) Review and Almarl (arottnolol Hydrochloride)(arotinolot, Hydrochloride) Label ). Patient was hospitalized.

6086874-X | Hepatomegaly, Jaundice, Splenomegaly
on Feb 05, 2009 Female patient from UNITED STATES , weighting 257.0 lb, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: hepatomegaly, jaundice (What is jaundice?), splenomegaly. Aldomet dosage: 250mg Daily, Po.

6045943-0 | Toxic Skin Eruption
Patient was taking Aldomet (View Usage). Patient had the following side effects: toxic skin eruption on Jan 14, 2009 from FRANCE Additional patient health information: Female patient , 94 years of age, was diagnosed with hypertension, arrhythmia (What is arrhythmia?) and. Aldomet dosage: . During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ).

5927305-7 | Blood Pressure Inadequately Controlled, Caesarean Section, Condition Aggravated, Foetal Distress Syndrome, Hypertensive Nephropathy, Iga Nephropathy, Pre-eclampsia
Adverse event was reported on Sep 10, 2008 by a Female patient taking Aldomet (View Usage) (Dosage: 1500 Mg/daily, Po, 375 Mg/daily, Po) was diagnosed with hypertension and. Location: JAPAN , 31 years of age, After Aldomet was administered, patient had the following side effects: blood pressure inadequately controlled, caesarean section, condition aggravated, foetal distress syndrome, hypertensive nephropathy, iga nephropathy, pre-eclampsia.

5920086-2 | Caesarean Section, Pre-eclampsia
on Sep 29, 2008 Female patient from SAUDI ARABIA , 36 years of age, was diagnosed with blood pressure abnormal and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, pre-eclampsia. Aldomet dosage: 500 Mg/tid Po. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), EPOETIN (View Epoetin Review and Epoetin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), IRON SUCROSE (View Iron Sucrose Review and Iron Sucrose Label ).

5918643-2 | Base Excess Negative, Blood Creatinine Increased, Blood Potassium Increased, Blood Pressure Inadequately Controlled, Blood Urea Increased, Caesarean Section, Foetal Growth Retardation, Premature Baby
on Sep 24, 2008 Female patient from JAPAN , 30 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient had the following side effects: base excess negative, blood creatinine increased, blood potassium increased, blood pressure inadequately controlled, blood urea increased, caesarean section, foetal growth retardation, premature baby. Aldomet dosage: Po. During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), INSULIN (View Insulin Review and Insulin Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ). Patient was hospitalized.

5902645-6 | Condition Aggravated, Deafness, Dysgeusia
Patient was taking Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: condition aggravated, deafness, dysgeusia on Sep 11, 2008 from JAPAN Additional patient health information: Female patient , 70 years of age, . Aldomet dosage: 500 Mg/daily Po, 750 Mg/daily Po.

5901651-5 | Pre-eclampsia
Adverse event was reported on Sep 23, 2008 by a Female patient taking Aldomet (View Usage) (Dosage: ) was diagnosed with hypertension, medical diet and. Location: MEXICO , 38 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: pre-eclampsia. During the same period patient was treated with HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), IRON POLYMALTOSE (View Iron Polymaltose Review and Iron Polymaltose Label ).

5901641-2 | Premature Baby, Small For Dates Baby
on Sep 23, 2008 Male patient from MEXICO , weighting 4.41 lb, was diagnosed with hypertension, medical diet and was treated with Aldomet (View Usage). Patient had the following side effects: premature baby, small for dates baby. Aldomet dosage: . During the same period patient was treated with HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), IRON POLYMALTOSE (View Iron Polymaltose Review and Iron Polymaltose Label ).

5895070-8 | Caesarean Section, Foetal Arrhythmia, Foetal Growth Retardation, Oligohydramnios, Premature Baby
on Aug 04, 2008 Female patient from FRANCE , 36 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: caesarean section, foetal arrhythmia, foetal growth retardation, oligohydramnios, premature baby. Aldomet dosage: 250 Mg, Tid, Po. During the same period patient was treated with ACEPROMETAZINE MALEATE (+) MEPROBAMATE (View Aceprometazine Maleate (+) Meprobamate Review and Aceprometazine Maleate (+) Meprobamate Label ), INSULIN (View Insulin Review and Insulin Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

5888651-9 | Blood Pressure Inadequately Controlled, Hypertensive Nephropathy, Iga Nephropathy, Renal Impairment
Patient was taking Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, hypertensive nephropathy, iga nephropathy, renal impairment on Sep 10, 2008 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with hypertension and. Aldomet dosage: .

5888644-1 | Foetal Distress Syndrome, Premature Baby, Small For Dates Baby
Adverse event was reported on Sep 10, 2008 by a Male patient taking Aldomet (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , weighting 2.20 lb, Patient had the following side effects: foetal distress syndrome, premature baby, small for dates baby.

5877384-0 | Blood Lactate Dehydrogenase Increased, Brain Natriuretic Peptide Increased, Cervical Root Pain, Chest Pain, Chills, Myocarditis, Pericardial Effusion
on Aug 25, 2008 Female patient from FRANCE , 42 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: blood lactate dehydrogenase increased, brain natriuretic peptide increased, cervical root pain, chest pain (What is chest pain?), chills, myocarditis, pericardial effusion. Aldomet dosage: 500 Mg/bid. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5873083-X | Blood Pressure Increased, Caesarean Section, Cardiomyopathy, Dyspnoea, No Therapeutic Response, Pleural Effusion, Protein Urine Present
on Aug 19, 2008 Female patient from JAPAN , 37 years of age, was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, caesarean section, cardiomyopathy (What is cardiomyopathy?), dyspnoea, no therapeutic response, pleural effusion, protein urine present. Aldomet dosage: Po.

5849030-3 | Blood Pressure Increased, Caesarean Section, Cardiac Failure, Cardiomyopathy, Dyspnoea, No Therapeutic Response, Pleural Effusion, Protein Urine Present
Patient was taking Aldomet (View Usage). Patient had the following side effects: blood pressure increased, caesarean section, cardiac failure, cardiomyopathy (What is cardiomyopathy?), dyspnoea, no therapeutic response, pleural effusion, protein urine present on Jul 30, 2008 from JAPAN Additional patient health information: Female patient , 37 years of age, . Aldomet dosage: Po.

5841986-8 | Foetal Arrhythmia, Foetal Growth Retardation, Premature Baby
Adverse event was reported on Aug 04, 2008 by a Female patient taking Aldomet (View Usage) (Dosage: ) was diagnosed with hypertension, diabetes mellitus, depression (What is depression?) and. Location: FRANCE , weighting 2.20 lb, After Aldomet was administered, patient had the following side effects: foetal arrhythmia, foetal growth retardation, premature baby. During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), INSULIN (View Insulin Review and Insulin Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), LABETALOL HYDROCHLORIDE (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), ACEPROMETAZINE MALEATE AND MEPROBAMATE (View Aceprometazine Maleate And Meprobamate Review and Aceprometazine Maleate And Meprobamate Label ). Patient was hospitalized.

5841938-8 | Oligohydramnios
on Aug 04, 2008 Female patient from FRANCE , 36 years of age, weighting 260.1 lb, was diagnosed with hypertension, diabetes mellitus, depression (What is depression?) and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: oligohydramnios. Aldomet dosage: . During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), INSULIN (View Insulin Review and Insulin Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), LABETALOL HYDROCHLORIDE (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), ACEPROMETAZINE MALEATE AND MEPROBAMATE (View Aceprometazine Maleate And Meprobamate Review and Aceprometazine Maleate And Meprobamate Label ). Patient was hospitalized.

5838656-9 | Foetal Arrhythmia, Foetal Growth Retardation
on Aug 04, 2008 Female patient from FRANCE , weighting 2.20 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Aldomet (View Usage). Patient had the following side effects: foetal arrhythmia, foetal growth retardation. Aldomet dosage: . During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), INSULIN (View Insulin Review and Insulin Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), LABETALOL HYDROCHLORIDE (View Labetalol Hydrochloride Review and Labetalol Hydrochloride Label ). Patient was hospitalized.

5825762-8 | Hepatomegaly, Jaundice, Splenomegaly
Patient was taking Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: hepatomegaly, jaundice (What is jaundice?), splenomegaly on Jul 28, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 257.0 lb, was diagnosed with hypertension and. Aldomet dosage: 250 Mg 1 Time Daily Po.

5797982-2 | Hepatic Enzyme Increased
Adverse event was reported on Jul 01, 2008 by a Female patient taking Aldomet (View Usage) (Dosage: 500 Mg By Mouth Bid) was diagnosed with hypertension and. Location: UNITED STATES , 32 years of age, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ).

5581014-5 | Back Pain, Oligohydramnios, Purpura
on Dec 21, 2007 Female patient from CANADA , 31 years of age, weighting 119.0 lb, was diagnosed with pregnancy induced hypertension and was treated with Aldomet (View Usage). Patient had the following side effects: back pain (What is back pain?), oligohydramnios, purpura. Aldomet dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

5563278-7 | Hellp Syndrome, Renal Failure Acute
on Dec 12, 2007 Female patient from JAPAN , 36 years of age, weighting 119.0 lb, was diagnosed with pregnancy induced hypertension and was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: hellp syndrome, renal failure acute. Aldomet dosage: . During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), GABEXATE MESYLATE (View Gabexate Mesylate Review and Gabexate Mesylate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), ALBUMIN HUMAN (View Albumin Human Review and Albumin Human Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ).

5505403-X | Hellp Syndrome, Renal Failure Acute
Patient was taking Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: hellp syndrome, renal failure acute on Oct 29, 2007 from JAPAN Additional patient health information: Female patient , 36 years of age, weighting 119.0 lb, was diagnosed with pregnancy induced hypertension and. Aldomet dosage: . During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), GABEXATE MESYLATE (View Gabexate Mesylate Review and Gabexate Mesylate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), ALBUMIN HUMAN (View Albumin Human Review and Albumin Human Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ).

5504017-5 | Hellp Syndrome, Renal Failure Acute
Adverse event was reported on Oct 24, 2007 by a Female patient taking Aldomet (View Usage) (Dosage: ) was diagnosed with pregnancy induced hypertension and. Location: JAPAN , 36 years of age, weighting 119.0 lb, Patient had the following side effects: hellp syndrome, renal failure acute. During the same period patient was treated with RITODRINE HYDROCHLORIDE (View Ritodrine Hydrochloride Review and Ritodrine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), GABEXATE MESYLATE (View Gabexate Mesylate Review and Gabexate Mesylate Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), ALBUMIN HUMAN (View Albumin Human Review and Albumin Human Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ).

5493943-1 | Foetal Disorder, Respiratory Disorder
on Sep 19, 2007 Male patient from JAPAN , weighting 4.41 lb, was treated with Aldomet (View Usage). After Aldomet was administered, patient had the following side effects: foetal disorder, respiratory disorder. Aldomet dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

5493361-6 | Abdominal Pain Upper, Blood Pressure Inadequately Controlled, Hellp Syndrome, Oedema, Proteinuria
on Oct 19, 2007 Female patient from JAPAN , 37 years of age, was diagnosed with hypertension and was treated with Aldomet (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood pressure inadequately controlled, hellp syndrome, oedema, proteinuria. Aldomet dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

5490839-6 | Blood Pressure Increased, Breech Presentation, Glomerulonephritis Chronic, Protein Urine Present
Patient was taking Aldomet (View Usage). Patient had the following side effects: blood pressure increased, breech presentation, glomerulonephritis chronic, protein urine present on Oct 10, 2007 from JAPAN Additional patient health information: Female patient , 21 years of age, . Aldomet dosage: . Patient was hospitalized.